AINewsBreaks Archive - Page 3 of 47

ThursdayOct 30, 2025 11:11 am

AINewsBreaks – HeartBeam Inc. (NASDAQ: BEAT) Schedules Third Quarter 2025 Conference Call for Nov. 13

HeartBeam (NASDAQ: BEAT), a medical technology company transforming cardiac care through personalized insights, will hold a conference call on Thursday, Nov. 13, 2025, at 4:30 p.m. ET to discuss its third quarter results for the period ended Sept. 30, 2025. The Company will also provide updates on regulatory progress, commercial-readiness activities, and upcoming milestones. A detailed press release will be issued prior to the call. To view the full press release, visit https://ibn.fm/ZCQli About HeartBeam, Inc. HeartBeam, Inc. (NASDAQ: BEAT) is a medical technology company dedicated to transforming the detection and monitoring of critical cardiac conditions. The Company is creating…

ThursdayOct 30, 2025 9:00 am

AINewsBreaks – D-Wave Quantum to Report Third Quarter Fiscal Year 2025 Financial Results on November 6, 2025

D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software and services, will release its financial results for the third quarter of fiscal year 2025 ended September 30, 2025 on Thursday, November 6 before market open. The press release will be available on the D-Wave Investor Relations website: https://ir.dwavesys.com/. In conjunction with this announcement, D-Wave will host a conference call on Thursday, November 6, 2025, at 8:00 a.m. (Eastern Time), to discuss the Company’s financial results and business outlook. The live dial-in number is 1-844-826-3035 (domestic) or 1-412-317-5195 (international). Participants can use those dial-in numbers or can click this link for instant…

ThursdayOct 30, 2025 9:00 am

AINewsBreaks – Lantern Pharma (NASDAQ: LTRN) to Present AI Drug Discovery Platforms at Inaugural AI4BM Symposium

Lantern Pharma (NASDAQ: LTRN) will present its commercially deployed AI research platforms, predictBBB.ai and LBx-AI, at the inaugural AI for Biology and Medicine symposium hosted by the University of North Texas. The company will showcase how machine learning is accelerating drug development and precision oncology, including 94.1% accuracy in predicting blood-brain barrier permeability and 86% accuracy in treatment response prediction for non-small cell lung cancer. CEO Panna Sharma said the presentations highlight Lantern’s mission to democratize advanced computational tools and reshape how pharmaceutical companies approach discovery, biomarker development, and CNS-targeted therapeutics. To view the full press release, visit https://ibn.fm/UpeZx About…

WednesdayOct 29, 2025 3:36 pm

AINewsBreaks – Micropolis Holding Co. (NYSE American: MCRP) Broadens Global Reach—New Agreement Signals Push into Emerging Markets

Micropolis (NYSE American: MCRP), a pioneer in unmanned ground vehicles (“UGVs”) and AI-driven robotics solutions, recently announced a major step in its international expansion strategy through an exclusive distribution agreement with AERXIO FZ-LLC. An article discussing this reads, “AERXIO, a UAE-based technology provider, will serve as the sole distributor of Micropolis’s advanced unmanned ground security vehicles and related technologies across Egypt and North Africa… The agreement provides AERXIO exclusive rights to market Micropolis’s ‘The Patrol’ platform. This autonomous unit is designed for both open-road and desert environments, with operational speeds of up to 50 km/h, a 15-hour runtime, rapid charging,…

WednesdayOct 29, 2025 2:49 pm

AINewsBreaks – Nightfood Holdings Inc. (NGTF) Bringing Robotic Innovation to the Forefront of Hospitality

Nightfood Holdings (OTCQB: NGTF) is eying opportunity in the evolving landscape of hospitality. A recent article discussing this reads, “Robotics and automation are no longer futuristic aspirations; they are rapidly reshaping hospitality operations today. Nightfood is pioneering this transformation with advanced AI-enabled robotic solutions designed to elevate service quality, optimize operational efficiency and enhance guest experience across the industry… Nightfood Holdings is positioning itself as an innovative leader. Through its subsidiary, the company is focused on hospitality automation. Operating as RoboOp365, FHVH develops AI-robotic systems aimed at streamlining operations within food service and guest-facing environments. This includes showcasing its AI-driven kitchen…

WednesdayOct 29, 2025 2:16 pm

AINewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) to Acquire API Media, Expanding AI-Driven Data Monetization and Media Capabilities

Datavault AI (NASDAQ: DVLT), a leader in patented data tokenization and monetization technologies, announced it has entered a definitive agreement to acquire API Media in December 2025. The acquisition will expand Datavault’s AI-powered data activation and monetization capabilities while preserving API’s brand and strengthening its operations with Datavault’s patented technologies. API Media, based in New Jersey, provides advanced audio, visual, and IT services for premier sports venues and enterprise clients. “This acquisition marks a decisive next step in our strategy to scale Datavault’s proprietary data-monetization ecosystem,” said Nathaniel Bradley, CEO of Datavault AI. “API Media’s brand and expertise will enrich our culture and enhance the value we deliver to enterprise clients…

TuesdayOct 28, 2025 1:55 pm

AINewsBreaks – MAX Power Mining (CSE: MAXX) (OTC: MAXXF) (FRANKFURT: 89N) Unveils AI-Assisted Large Earth Model Integration for Natural Hydrogen Exploration

This article has been disseminated on behalf of MAX Power Mining and may include paid advertising. MAX Power Mining (CSE: MAXX) (OTC: MAXXF) (FRANKFURT: 89N) announced the development of its MAX Power Large Earth Model Integration (“MAXX LEMI”) for Natural Hydrogen, an advanced exploration system soon to be enhanced by artificial intelligence as part of the Company’s push toward the world’s first commercial Natural Hydrogen discovery. Canada’s first deep well targeting Natural Hydrogen is expected to begin drilling around Nov. 7 on MAX Power’s 200-km-long Genesis Trend in southern Saskatchewan, with additional wells planned across its 1.3-million-acre land package. Overseen by Chief…

TuesdayOct 28, 2025 12:08 pm

AINewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Licenses Carbon Credit Tokenization System to Nature’s Miracle (OTCQB: NMHI) in $2 Million Global Agreement

Datavault AI (NASDAQ: DVLT), a leader in patented data tokenization and monetization technologies, today announced a definitive licensing agreement with Nature’s Miracle Holding Inc. (OTCQB: NMHI), a sustainable agriculture and environmental technology company. Under the deal, Nature’s Miracle will license Datavault AI’s patented Carbon Credit Tokenization System, gaining global rights to develop, distribute, and commercialize blockchain-powered carbon credit solutions. Datavault AI will receive a non-refundable $2 million license fee and a 35% royalty on all gross revenue from the technology. “This agreement represents a significant milestone in Datavault AI’s ongoing strategy to commercialize our patent portfolio across high-growth industries like…

TuesdayOct 28, 2025 12:00 pm

AINewsBreaks – Beeline Holdings, Inc. (NASDAQ: BLNE) CEO Highlights Blockchain Home-Equity Platform Launch in Exclusive Benzinga Interview

Beeline Holdings (NASDAQ: BLNE) CEO and Co-Founder Nick Liuzza discussed the company’s growth trajectory and industry outlook in an exclusive interview with Benzinga, following the launch of BeelineEquity, the nation’s first blockchain-powered home-equity platform. The platform enables homeowners—particularly baby boomers seeking liquidity—to sell fractional equity in their properties without taking on debt or monthly payments, with each transaction tokenized on blockchain. Liuzza told Benzinga that Beeline closed five equity transactions last week, expects about 25 more within 45 days, and is already taking 2026 applications amid strong demand. He said the company plans to scale nationwide as anticipated interest rate…

TuesdayOct 28, 2025 11:00 am

AINewsBreaks – Lantern Pharma (NASDAQ: LTRN) Reports Complete Metabolic Response in Phase 1 LP-284 Trial at LL&M Congress

Lantern Pharma (NASDAQ: LTRN), a clinical-stage biopharmaceutical company using its RADR(R) AI platform to transform oncology drug discovery and development, presented clinical data from its ongoing Phase 1 trial of LP-284 at the 25th Annual Lymphoma, Leukemia & Myeloma Congress in New York City, showing a confirmed complete metabolic response in a 41-year-old patient with aggressive Grade 3 non-germinal center B-cell diffuse large B-cell lymphoma after failure of four prior regimens, including CAR-T and bispecific antibody therapies. The response, achieved after two 28-day cycles of LP-284, supports the drug’s synthetic lethal mechanism and potential to fill a critical post-immunotherapy treatment…

AINewsWire provides insights in the emerging sector of Artificial Intelligence.

Contact us: (512) 354-7000

AINewsBreaks